Diabetes Device Coined Precursor to Artificial Pancreas

A new medical tool that requires limited human contribution will be made available to those who generally struggle to regulate their type 1 diabetes.

The diabetes device has been defined as the precursor to an artificial pancreas, with an independent National Institute for Health and Care Excellence (NICE) board endorsing the closed loop device for regulating blood glucose levels.

It sends information to an insulin pump attached to the patient’s body, which then calculates how much insulin must be injected to maintain safe blood glucose levels. This enables patients to live day-to-day and not have to constantly check their blood glucose levels.

Patients are frequently in danger of developing more permanent problems including blindness, amputations, or renal issues when their condition is not effectively controlled.

NICE has advised that those who are given the option of using the new technology should be unable to maintain stable condition using a traditional insulin pump, unable to perform ongoing glucose observation, or vulnerable to developing longstanding problems.

Furthermore, individuals who are expecting children or who are preparing to become pregnant are also entitled to the device since blood sugar levels are more difficult to control in this period.

Mark Chapman, NICE’s temporary director of medical technology, said that “this technology is the best intervention to help them control their diabetes, barring a cure.”

“Our committee has reviewed the real-world data generated by the NHS and evidence generated by randomised controlled trials which show there are clear benefits of recommending the technology’s use.”

They will be working with NHS England and industry to ensure a cost-effective price can be reached which is fair to taxpayers.”

Approximately 105 thousand people in England will be given access to the medical tool, this is an estimated 38% of the total individuals with type 1 diabetes in England and Wales.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.